Cargando…
Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment?
Metabolic disorder is a modifiable risk factor for cardiovascular diseases (CVD), and lifestyle modification is the key to improving metabolic disorder. Diabetes mellitus has been shown to be a risk factor for coronary heart disease (CHD) and ischemic stroke in both Western and Japanese populations....
Autor principal: | Kokubo, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405375/ https://www.ncbi.nlm.nih.gov/pubmed/23199129 http://dx.doi.org/10.1007/s13167-011-0074-1 |
Ejemplares similares
-
Treating diabetic dyslipidemia: What have we learnt from recent clinical trials?
por: Tan, Kathryn CB
Publicado: (2010) -
Cardiovascular imaging: what have we learned from animal models?
por: Santos, Arnoldo, et al.
Publicado: (2015) -
What have we learned?
por: Rodgers, Peter, et al.
Publicado: (2021) -
Neutrinos, what we have learned about them and what we have learned using them
por: Steinberger, J
Publicado: (2013) -
Psychological Interventions for Dementia Caregivers: What We Have Achieved, What We Have Learned
por: Cheng, Sheung-Tak, et al.
Publicado: (2019)